Effect of jianpi bushen formula for colon cancer patients who underwent adjuvant chemotherapy: Statistical analysis plan for a multicenter trial Journal Article


Authors: Zhao, R.; Cao, H.; Sun, L.; Zhang, T.; Xu, Y.; Yan, S.; Mao, J.; Liu, J.; Fei, Y.; Yang, Y.
Article Title: Effect of jianpi bushen formula for colon cancer patients who underwent adjuvant chemotherapy: Statistical analysis plan for a multicenter trial
Abstract: Background: Patients with colon cancer who receive chemotherapy usually experience various gastrointestinal adverse reactions, including nausea, vomiting, and diarrhea, which make it challenging for them to adhere to treatment. As an effective traditional Chinese medicine, the Jianpi Bushen formula has been widely used to alleviate the side effects of chemotherapy. Objective: To evaluate the efficacy and safety of Jianpi Bushen formulae for patients who undergo chemotherapy. This statistical analysis plan (SAP) is intended to enhance the transparency and research quality of our randomized controlled trial. Methods: Our study is a multicenter, double-blind, randomized controlled clinical trial. This trial aimed to compare the completion rate of chemotherapy in colon cancer patients who are using and not using Jianpi Bushen formula. To attenuate possible selection bias in the final report, we declared the overall trial design, outcome measures, subgroup analyses, and safety measures. Also, we described the data management and statistical analysis methods in detail. Conclusion: The SAP provides more detailed information than the trial protocol for data management and statistical analysis methods. Further post-hoc analyses can be performed by referring to the SAP, and possible selection bias can be attenuated. © 2023 Beijing University of Chinese Medicine
Keywords: adult; controlled study; aged; survival rate; unclassified drug; placebo; drug efficacy; drug safety; side effect; treatment duration; capecitabine; comparative study; chemotherapy; outcome assessment; multiple cycle treatment; randomized controlled trial; drug effect; disease severity; multicenter study; colon cancer; adjuvant chemotherapy; plant medicinal product; ligustrum lucidum extract; oxaliplatin; double blind procedure; study design; traditional chinese medicine; human; male; female; article; angelica sinensis extract; statistical analysis plan; astragalus root; atractylodes macrocephala extract; chinese medicinal formula; cuscuta chinensis extract; jianpi bushen; pinellia extract; poria cocos extract; radix pseudostellariae; atractylodes macrocephala; cuscuta chinensis; ligustrum lucidum; pseudostellaria; wolfiporia cocos
Journal Title: Journal of Traditional Chinese Medical Sciences
Volume: 10
Issue: 1
ISSN: 2095-7548
Publisher: Tsinghua University Press  
Date Published: 2023-01-01
Start Page: 58
End Page: 63
Language: English
DOI: 10.1016/j.jtcms.2022.11.009
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 March 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jun J Mao
    243 Mao